title: [Mediastinal fibrosis and mirtazapin].
abstract: We report a 61-year-old woman who developed a superior vena cava syndrome due to mediastinal fibrosis. This mediastinal fibrosis resolved after the discontinuation of a chronic treatment by mirtazapin that the patient was receiving for the previous six years, suggesting a role of this treatment in the genesis of the mediastinal fibrosis.
authors.affiliation: Service de médecine interne, hôpitaux IRIS sud, 63, rue Jean-Paquot, 1050 Bruxelles, Belgique. anisakakalay@hotmail.com
authors.forename: A
authors.initials: A
authors.lastname: Akalay
authors.forename: M
authors.initials: M
authors.lastname: Ost
authors.forename: B
authors.initials: B
authors.lastname: Hanson
mesh_terms: D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects*; D005260:Female; D005355:Fibrosis; D006801:Humans; D008482:Mediastinum / Q000473:pathology*; D008803:Mianserin / Q000009:adverse effects / Q000031:analogs & derivatives*; D008875:Middle Aged; D000078785:Mirtazapine; D013479:Superior Vena Cava Syndrome / Q000209:etiology
chemical_list: D000929:Antidepressive Agents, Tricyclic; D008803:Mianserin; D000078785:Mirtazapine